Geron Corporation (GERN)
USD 1.28
(-9.22%)
USD 1.28
(-9.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -184.12 Million USD | -30.56% |
| 2022 | -141.03 Million USD | -16.6% |
| 2021 | -120.95 Million USD | -59.97% |
| 2020 | -75.61 Million USD | -18.98% |
| 2019 | -63.55 Million USD | -135.23% |
| 2018 | -27.01 Million USD | 3.22% |
| 2017 | -27.91 Million USD | 5.49% |
| 2016 | -29.53 Million USD | -64310.87% |
| 2015 | 46 Thousand USD | 100.13% |
| 2014 | -35.67 Million USD | 7.06% |
| 2013 | -38.37 Million USD | 44.28% |
| 2012 | -68.88 Million USD | 28.88% |
| 2011 | -96.85 Million USD | 13.04% |
| 2010 | -111.37 Million USD | -58.69% |
| 2009 | -70.18 Million USD | -13.16% |
| 2008 | -62.02 Million USD | -69.01% |
| 2007 | -36.69 Million USD | -17.0% |
| 2006 | -31.36 Million USD | 6.45% |
| 2005 | -33.52 Million USD | 58.3% |
| 2004 | -80.4 Million USD | -169.07% |
| 2003 | -29.88 Million USD | 11.87% |
| 2002 | -33.9 Million USD | 19.41% |
| 2001 | -42.07 Million USD | 8.2% |
| 2000 | -45.83 Million USD | 1.22% |
| 1999 | -46.4 Million USD | -329.63% |
| 1998 | -10.8 Million USD | -12.5% |
| 1997 | -9.6 Million USD | 10.28% |
| 1996 | -10.7 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -55.39 Million USD | -6.57% |
| 2024 Q2 | -67.38 Million USD | -21.65% |
| 2023 Q3 | -44.8 Million USD | 8.98% |
| 2023 FY | -184.12 Million USD | -30.56% |
| 2023 Q2 | -49.22 Million USD | -29.29% |
| 2023 Q4 | -51.97 Million USD | -16.0% |
| 2023 Q1 | -38.07 Million USD | 10.22% |
| 2022 Q1 | -31.52 Million USD | 1.55% |
| 2022 FY | -141.03 Million USD | -16.6% |
| 2022 Q4 | -42.4 Million USD | -3.87% |
| 2022 Q3 | -40.82 Million USD | -44.48% |
| 2022 Q2 | -28.25 Million USD | 10.35% |
| 2021 Q2 | -29.57 Million USD | -6.29% |
| 2021 Q3 | -26.69 Million USD | 9.73% |
| 2021 Q4 | -32.01 Million USD | -19.93% |
| 2021 Q1 | -27.82 Million USD | -16.97% |
| 2021 FY | -120.95 Million USD | -59.97% |
| 2020 Q4 | -23.78 Million USD | -21.05% |
| 2020 Q2 | -15.82 Million USD | 3.25% |
| 2020 Q1 | -16.35 Million USD | 43.74% |
| 2020 FY | -75.61 Million USD | -18.98% |
| 2020 Q3 | -19.65 Million USD | -24.18% |
| 2019 Q4 | -29.07 Million USD | -91.5% |
| 2019 Q3 | -15.18 Million USD | -6.61% |
| 2019 FY | -63.55 Million USD | -135.23% |
| 2019 Q2 | -14.23 Million USD | -41.55% |
| 2019 Q1 | -10.05 Million USD | -37.79% |
| 2018 Q1 | -7.18 Million USD | 3.27% |
| 2018 Q3 | -5.59 Million USD | 19.28% |
| 2018 FY | -27.01 Million USD | 3.22% |
| 2018 Q4 | -7.3 Million USD | -30.43% |
| 2018 Q2 | -6.93 Million USD | 3.51% |
| 2017 Q1 | -7.18 Million USD | 15.31% |
| 2017 FY | -27.91 Million USD | 5.49% |
| 2017 Q4 | -7.42 Million USD | -7.68% |
| 2017 Q3 | -6.89 Million USD | -7.71% |
| 2017 Q2 | -6.4 Million USD | 10.83% |
| 2016 FY | -29.53 Million USD | -64310.87% |
| 2016 Q3 | -3.57 Million USD | 58.6% |
| 2016 Q1 | -8.84 Million USD | -4.42% |
| 2016 Q2 | -8.63 Million USD | 2.32% |
| 2016 Q4 | -8.48 Million USD | -137.19% |
| 2015 FY | 46 Thousand USD | 100.13% |
| 2015 Q2 | -9.35 Million USD | -0.44% |
| 2015 Q4 | -8.46 Million USD | -131.15% |
| 2015 Q3 | 27.18 Million USD | 390.56% |
| 2015 Q1 | -9.31 Million USD | -4.11% |
| 2014 Q3 | -9.54 Million USD | -9.33% |
| 2014 Q4 | -8.94 Million USD | 6.3% |
| 2014 FY | -35.67 Million USD | 7.06% |
| 2014 Q1 | -8.44 Million USD | 9.06% |
| 2014 Q2 | -8.73 Million USD | -3.48% |
| 2013 Q2 | -8.94 Million USD | 24.8% |
| 2013 Q3 | -8.25 Million USD | 7.75% |
| 2013 Q4 | -9.28 Million USD | -12.44% |
| 2013 FY | -38.37 Million USD | 44.28% |
| 2013 Q1 | -11.89 Million USD | 25.0% |
| 2012 Q2 | -18.32 Million USD | 2.2% |
| 2012 Q3 | -15.95 Million USD | 12.95% |
| 2012 Q4 | -15.86 Million USD | 0.56% |
| 2012 FY | -68.88 Million USD | 28.88% |
| 2012 Q1 | -18.73 Million USD | 41.17% |
| 2011 Q3 | -19.52 Million USD | 7.43% |
| 2011 Q1 | -24.38 Million USD | 58.91% |
| 2011 Q4 | -31.85 Million USD | -63.17% |
| 2011 Q2 | -21.08 Million USD | 13.53% |
| 2011 FY | -96.85 Million USD | 13.04% |
| 2010 Q3 | -18.34 Million USD | -7.71% |
| 2010 Q1 | -16.64 Million USD | 9.52% |
| 2010 Q4 | -59.36 Million USD | -223.6% |
| 2010 Q2 | -17.03 Million USD | -2.35% |
| 2010 FY | -111.37 Million USD | -58.69% |
| 2009 Q4 | -18.39 Million USD | -20.8% |
| 2009 Q2 | -19.75 Million USD | -17.53% |
| 2009 Q1 | -16.81 Million USD | 4.66% |
| 2009 Q3 | -15.22 Million USD | 22.95% |
| 2009 FY | -70.18 Million USD | -13.16% |
| 2008 Q3 | -17.15 Million USD | -26.45% |
| 2008 Q2 | -13.56 Million USD | 0.8% |
| 2008 FY | -62.02 Million USD | -69.01% |
| 2008 Q1 | -13.67 Million USD | -23.8% |
| 2008 Q4 | -17.63 Million USD | -2.8% |
| 2007 Q2 | -13.98 Million USD | -1298.37% |
| 2007 Q4 | -11.04 Million USD | 13.94% |
| 2007 Q3 | -12.83 Million USD | 8.23% |
| 2007 FY | -36.69 Million USD | -17.0% |
| 2007 Q1 | 1.16 Million USD | 135.79% |
| 2006 FY | -31.36 Million USD | 6.45% |
| 2006 Q4 | -3.26 Million USD | 66.85% |
| 2006 Q3 | -9.83 Million USD | -6.27% |
| 2006 Q2 | -9.25 Million USD | -2.74% |
| 2006 Q1 | -9.01 Million USD | -1.28% |
| 2005 FY | -33.52 Million USD | 58.3% |
| 2005 Q4 | -8.89 Million USD | 25.0% |
| 2005 Q3 | -11.86 Million USD | -284.88% |
| 2005 Q2 | -3.08 Million USD | 68.19% |
| 2005 Q1 | -9.68 Million USD | -2.25% |
| 2004 FY | -80.4 Million USD | -169.07% |
| 2004 Q2 | -8.94 Million USD | 82.69% |
| 2004 Q4 | -9.47 Million USD | 8.03% |
| 2004 Q1 | -51.68 Million USD | -584.0% |
| 2004 Q3 | -10.3 Million USD | -15.17% |
| 2003 Q1 | -7.93 Million USD | -9.72% |
| 2003 FY | -29.88 Million USD | 11.87% |
| 2003 Q4 | -7.55 Million USD | -47.95% |
| 2003 Q3 | -5.1 Million USD | 45.02% |
| 2003 Q2 | -9.28 Million USD | -17.1% |
| 2002 Q2 | -9 Million USD | 14.0% |
| 2002 Q3 | -7.19 Million USD | 20.12% |
| 2002 Q4 | -7.22 Million USD | -0.46% |
| 2002 FY | -33.9 Million USD | 19.41% |
| 2002 Q1 | -10.47 Million USD | 46.13% |
| 2001 Q2 | -6.08 Million USD | 18.22% |
| 2001 Q3 | -9.11 Million USD | -49.84% |
| 2001 FY | -42.07 Million USD | 8.2% |
| 2001 Q1 | -7.43 Million USD | 53.3% |
| 2001 Q4 | -19.44 Million USD | -113.39% |
| 2000 Q1 | -6.59 Million USD | 18.59% |
| 2000 Q4 | -15.92 Million USD | -223.13% |
| 2000 Q3 | -4.92 Million USD | 70.13% |
| 2000 Q2 | -16.49 Million USD | -150.2% |
| 2000 FY | -45.83 Million USD | 1.22% |
| 1999 FY | -46.4 Million USD | -329.63% |
| 1999 Q2 | -28 Million USD | -748.48% |
| 1999 Q3 | -6.9 Million USD | 75.36% |
| 1999 Q4 | -8.1 Million USD | -17.39% |
| 1999 Q1 | -3.3 Million USD | 10.81% |
| 1998 FY | -10.8 Million USD | -12.5% |
| 1998 Q2 | -2.4 Million USD | -26.32% |
| 1998 Q3 | -2.8 Million USD | -16.67% |
| 1998 Q4 | -3.7 Million USD | -32.14% |
| 1998 Q1 | -1.9 Million USD | -35.71% |
| 1997 Q3 | -2 Million USD | -11.11% |
| 1997 FY | -9.6 Million USD | 10.28% |
| 1997 Q2 | -1.8 Million USD | 59.09% |
| 1997 Q1 | -4.4 Million USD | -41.94% |
| 1997 Q4 | -1.4 Million USD | 30.0% |
| 1996 Q1 | -2.4 Million USD | 0.0% |
| 1996 Q4 | -3.1 Million USD | -14.81% |
| 1996 Q2 | -2.5 Million USD | -4.17% |
| 1996 FY | -10.7 Million USD | 0.0% |
| 1996 Q3 | -2.7 Million USD | -8.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -254.602% |
| Jaguar Health, Inc. | -41.3 Million USD | -345.828% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -20.351% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -238.332% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 58.176% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 453.045% |
| ContextLogic Inc. | -317 Million USD | 41.916% |
| MiMedx Group, Inc. | 67.43 Million USD | 373.027% |
| MEI Pharma, Inc. | 17.77 Million USD | 1135.701% |
| AlloVir, Inc. | -190.41 Million USD | 3.304% |
| Novavax, Inc. | -545.06 Million USD | 66.219% |
| Aptorum Group Limited | -2.82 Million USD | -6418.584% |
| Ardelyx, Inc. | -66.06 Million USD | -178.697% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 10.302% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -259.911% |
| Vaxcyte, Inc. | -402.26 Million USD | 54.228% |
| Precigen, Inc. | -95.9 Million USD | -91.991% |
| Pharming Group N.V. | -10.54 Million USD | -1645.611% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 8.664% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -650.222% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -633.837% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 13.238% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -892.807% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -656.501% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -656.501% |
| Bicycle Therapeutics plc | -180.66 Million USD | -1.917% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 28.586% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -575.993% |
| Acelyrin, Inc. | -381.64 Million USD | 51.754% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -393.109% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -439.946% |
| Senti Biosciences, Inc. | -92.91 Million USD | -98.159% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -75.863% |
| AbCellera Biologics Inc. | -146.39 Million USD | -25.772% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -423.981% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -2.834% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -2654.331% |
| Chimerix, Inc. | -82.09 Million USD | -124.285% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -527.093% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -807.432% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -312.81% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -260.623% |
| Elevation Oncology, Inc. | -45.7 Million USD | -302.868% |
| Alkermes plc | 355.75 Million USD | 151.756% |
| Fortress Biotech, Inc. | -60.63 Million USD | -203.655% |
| Fortress Biotech, Inc. | -60.63 Million USD | -203.655% |
| Agenus Inc. | -245.76 Million USD | 25.079% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -125.701% |
| Dyadic International, Inc. | -6.79 Million USD | -2609.559% |
| ImmuCell Corporation | -5.77 Million USD | -3088.568% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -19571.688% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -63.001% |
| Lantern Pharma Inc. | -15.96 Million USD | -1053.567% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1093.611% |
| Incyte Corporation | 597.59 Million USD | 130.811% |
| IO Biotech, Inc. | -86.08 Million USD | -113.895% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -215.865% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -867.619% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -212.171% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -11.881% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2065.945% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -151.035% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 50.719% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 67.857% |
| NextCure, Inc. | -62.72 Million USD | -193.556% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -1743.851% |
| Onconetix, Inc. | -37.4 Million USD | -392.191% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -366.392% |
| Opthea Limited | -220.24 Million USD | 16.398% |
| PDS Biotechnology Corporation | -42.94 Million USD | -328.779% |
| PureTech Health plc | -65.69 Million USD | -180.267% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -149.528% |
| Seer, Inc. | -86.27 Million USD | -113.414% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1467902.478% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -466.806% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1308.575% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -547.15% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -220.148% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -195.763% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -38.971% |
| ChromaDex Corporation | -4.93 Million USD | -3628.777% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -5031.745% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -80.393% |
| CRISPR Therapeutics AG | -153.61 Million USD | -19.867% |
| Precision BioSciences, Inc. | -61.31 Million USD | -200.277% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -14.416% |
| Innoviva, Inc. | 179.72 Million USD | 202.451% |
| Summit Therapeutics Inc. | -614.92 Million USD | 70.057% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -174.837% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -179.977% |
| ESSA Pharma Inc. | -26.58 Million USD | -592.667% |
| GlycoMimetics, Inc. | -36.89 Million USD | -398.997% |
| GT Biopharma, Inc. | -7.59 Million USD | -2323.68% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 23.713% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 357.845% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -274.851% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -1750.942% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 25.028% |
| Aptose Biosciences Inc. | -51.2 Million USD | -259.574% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -87.315% |
| Soligenix, Inc. | -6.14 Million USD | -2898.455% |
| Century Therapeutics, Inc. | -136.67 Million USD | -34.721% |
| Kura Oncology, Inc. | -152.63 Million USD | -20.635% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -106.379% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -1647.267% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 32661.763% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -32259.754% |
| Autolus Therapeutics plc | -208.38 Million USD | 11.64% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -156.095% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -160.085% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -749.765% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 18.257% |
| GRI Bio, Inc. | -13.03 Million USD | -1312.342% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -4353.344% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -48.389% |
| IGM Biosciences, Inc. | -246.41 Million USD | 25.278% |
| INmune Bio, Inc. | -30 Million USD | -513.593% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -66.542% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -336.384% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1053.558% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1065.731% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -208.498% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -82.003% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 33.318% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 22.601% |
| Verastem, Inc. | -87.36 Million USD | -110.751% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -239.793% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -14.126% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -57.835% |
| Histogen Inc. | -10.62 Million USD | -1633.613% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1188.795% |
| Surrozen, Inc. | -43.04 Million USD | -327.784% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1155.041% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -3519.539% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -251.797% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -628.841% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -583.521% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2103.244% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -21.87% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -276.337% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -519.435% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -1667.443% |
| Apollomics, Inc. | -172.6 Million USD | -6.678% |
| Amarin Corporation plc | -59.11 Million USD | -211.488% |
| Mesoblast Limited | -87.95 Million USD | -109.34% |
| Turnstone Biologics Corp. | -55.2 Million USD | -233.563% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -25.289% |
| Synaptogenix, Inc. | -6.03 Million USD | -2949.216% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1036.025% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -136.0% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -3742.811% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2091.415% |
| Exelixis, Inc. | 207.76 Million USD | 188.623% |
| Better Therapeutics, Inc. | -39.76 Million USD | -363.096% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -27.912% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 65.169% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1412.706% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -2262.211% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -498.806% |
| Gritstone bio, Inc. | -138.49 Million USD | -32.953% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -185.623% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -4503.233% |
| Avid Bioservices, Inc. | -140.75 Million USD | -30.816% |
| Insmed Incorporated | -749.56 Million USD | 75.436% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1112.199% |
| MediWound Ltd. | -6.71 Million USD | -2641.617% |
| OmniAb, Inc. | -50.61 Million USD | -263.751% |
| Alector, Inc. | -130.39 Million USD | -41.211% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -61.907% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -255.135% |
| Zai Lab Limited | -334.62 Million USD | 44.974% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 43.168% |
| Aura Biosciences, Inc. | -76.4 Million USD | -140.979% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 21.525% |
| Immunic, Inc. | -93.61 Million USD | -96.692% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -35.494% |
| Veracyte, Inc. | -74.4 Million USD | -147.469% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -2298.877% |
| FibroGen, Inc. | -284.23 Million USD | 35.219% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -601.918% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -2529.676% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -877.699% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 144.386% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -716.347% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 473.703% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1553.022% |
| Galecto, Inc. | -38.34 Million USD | -380.135% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -875.973% |
| Fortrea Holdings Inc. | -3.4 Million USD | -5315.5% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -45.389% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -957.533% |
| XBiotech Inc. | -24.55 Million USD | -649.794% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -185.623% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -193.757% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -87.072% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -759.322% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -233.606% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 69.648% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -169.763% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -323304.293% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 18.722% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -726.886% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 16.195% |
| NexImmune, Inc. | -32.34 Million USD | -469.27% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -3382.917% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1210.895% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 104.657% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -660.196% |
| Scopus BioPharma Inc. | -11.6 Million USD | -1485.958% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -57.646% |
| Ainos, Inc. | -13.77 Million USD | -1237.107% |
| Pluri Inc. | -20.88 Million USD | -781.497% |
| Prothena Corporation plc | -147.02 Million USD | -25.233% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -61.698% |
| Celularity Inc. | -196.29 Million USD | 6.199% |
| Rallybio Corporation | -74.56 Million USD | -146.938% |
| Cue Biopharma, Inc. | -50.73 Million USD | -262.933% |
| MeiraGTx Holdings plc | -84.02 Million USD | -119.128% |
| Omeros Corporation | -117.81 Million USD | -56.288% |
| Humacyte, Inc. | -110.77 Million USD | -66.216% |
| Immunocore Holdings plc | -55.28 Million USD | -233.039% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -923.838% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -702.961% |
| Blueprint Medicines Corporation | -506.98 Million USD | 63.682% |
| CalciMedica, Inc. | -34.35 Million USD | -435.923% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -172.075% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -30.213% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -11.061% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 34.996% |
| Pulmatrix, Inc. | -14.12 Million USD | -1203.923% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -423.162% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -122.812% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 61.735% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -75.575% |
| Cytokinetics, Incorporated | -526.24 Million USD | 65.011% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -410.542% |
| Nutriband Inc. | -5.48 Million USD | -3256.727% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -355.534% |
| Vor Biopharma Inc. | -117.86 Million USD | -56.221% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 104.234% |
| Evogene Ltd. | -23.87 Million USD | -671.083% |
| ProKidney Corp. | -35.46 Million USD | -419.136% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -53.743% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -2246.945% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 71.373% |
| CorMedix Inc. | -46.33 Million USD | -297.346% |
| BioLineRx Ltd. | -60.61 Million USD | -203.77% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -80.971% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -348.368% |
| Atai Life Sciences N.V. | -40.22 Million USD | -357.754% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -128.303% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -143.809% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 36.984% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -560.522% |
| MediciNova, Inc. | -8.57 Million USD | -2048.126% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -49.36% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2098.05% |
| GeoVax Labs, Inc. | -25.96 Million USD | -609.087% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 23.036% |
| Biomea Fusion, Inc. | -117.25 Million USD | -57.031% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 70.615% |
| Mereo BioPharma Group plc | -29.46 Million USD | -524.88% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -20.217% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 12.052% |
| Absci Corporation | -110.56 Million USD | -66.531% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -510.703% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -82.599% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 21.959% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1407.349% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 4.579% |
| Allakos Inc. | -185.7 Million USD | 0.848% |
| Imunon, Inc. | -19.51 Million USD | -843.516% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -89.168% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 273.476% |
| BioAtla, Inc. | -123.46 Million USD | -49.137% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1412.706% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1045.211% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 43.738% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -398.327% |
| XOMA Corporation | -40.83 Million USD | -350.949% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -80.747% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -55.364% |
| aTyr Pharma, Inc. | -50.38 Million USD | -265.411% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -110.001% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -21.329% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 22.549% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -424.295% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -2175.437% |
| Akari Therapeutics, Plc | -10 Million USD | -1739.798% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -273389.788% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 165.387% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2662.638% |
| UroGen Pharma Ltd. | -102.24 Million USD | -80.086% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -72.415% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -2267.528% |
| Orgenesis Inc. | -55.36 Million USD | -232.593% |
| Entera Bio Ltd. | -8.88 Million USD | -1971.403% |
| GH Research PLC | -35.58 Million USD | -417.4% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -783.527% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -137.927% |
| Xencor, Inc. | -126.08 Million USD | -46.032% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -4789.58% |
| Replimune Group, Inc. | -215.79 Million USD | 14.675% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -765.806% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 7438.661% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2662.638% |
| Portage Biotech Inc. | -75.33 Million USD | -144.398% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2098.05% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -90.499% |
| OncoCyte Corporation | -27.78 Million USD | -562.78% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1272.319% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -1555.592% |
| Purple Biotech Ltd. | -19.88 Million USD | -826.192% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -2523.265% |
| scPharmaceuticals Inc. | -54.81 Million USD | -235.937% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -951.785% |
| HilleVax, Inc. | -123.56 Million USD | -49.011% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -1721.777% |
| Tharimmune, Inc. | -9.31 Million USD | -1875.804% |
| Genprex, Inc. | -30.86 Million USD | -496.644% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 21.955% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -511.84% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -10232.604% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -3376.708% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1094235.608% |
| Savara Inc. | -54.69 Million USD | -236.625% |
| Curis, Inc. | -47.41 Million USD | -288.347% |
| Daré Bioscience, Inc. | -30.16 Million USD | -510.473% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1092.14% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -3206.285% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -517.565% |
| BeiGene, Ltd. | -881.7 Million USD | 79.117% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -764.69% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 57.805% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -133.205% |
| Erasca, Inc. | -125.04 Million USD | -47.252% |
| bluebird bio, Inc. | -211.91 Million USD | 13.112% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -3582.174% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 209.831% |
| DBV Technologies S.A. | -72.72 Million USD | -153.179% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -3582.174% |
| Moderna, Inc. | -4.71 Billion USD | 96.094% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -358.518% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -3133.702% |
| Molecular Templates, Inc. | -8.12 Million USD | -2166.457% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -204.907% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -65.286% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -36.036% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -284.246% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -30.19% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 4.305% |
| MacroGenics, Inc. | -9.05 Million USD | -1932.756% |
| RenovoRx, Inc. | -10.23 Million USD | -1699.521% |
| Adicet Bio, Inc. | -142.65 Million USD | -29.069% |
| Prime Medicine, Inc. | -198.13 Million USD | 7.069% |
| Aditxt, Inc. | -32.38 Million USD | -468.629% |
| Adagene Inc. | -18.94 Million USD | -871.833% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2418.244% |
| Quantum-Si incorporated | -95.96 Million USD | -91.879% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -54.691% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1163.067% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 239.142% |
| SciSparc Ltd. | -5.12 Million USD | -3494.826% |
| Vericel Corporation | -3.18 Million USD | -5686.518% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -153015.073% |
| Minerva Neurosciences, Inc. | -30 Million USD | -513.647% |
| Generation Bio Co. | -126.61 Million USD | -45.426% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -152.606% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -123.341% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 29.76% |
| Invivyd, Inc. | -198.64 Million USD | 7.308% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 46.157% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2019.674% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 907.362% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -1764.766% |
| 2seventy bio, Inc. | -217.57 Million USD | 15.371% |
| ADMA Biologics, Inc. | -28.23 Million USD | -552.031% |
| Clene Inc. | -49.5 Million USD | -271.944% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -726.143% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -272.47% |
| GeoVax Labs, Inc. | -25.96 Million USD | -609.087% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 43.875% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -465.798% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 910.418% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -86.379% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -146.311% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -14.503% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 70.064% |
| Evaxion Biotech A/S | -22.12 Million USD | -732.212% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -128.061% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 7.968% |
| Trevena, Inc. | -40.28 Million USD | -357.016% |
| Surrozen, Inc. | -43.04 Million USD | -327.784% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -166.333% |
| Cingulate Inc. | -23.53 Million USD | -682.356% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -2563.874% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -361.934% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -2287.95% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -104.109% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -200.439% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -209.442% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1440.163% |
| Kronos Bio, Inc. | -112.67 Million USD | -63.417% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -166.091% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -7259769.964% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -114.363% |
| Statera Biopharma, Inc. | -174.4 Million USD | -5.572% |
| ImmunityBio, Inc. | -583.19 Million USD | 68.428% |
| Korro Bio, Inc. | -81.17 Million USD | -126.836% |
| Kineta, Inc. | -14.09 Million USD | -1205.958% |
| BioVie Inc. | -32.12 Million USD | -473.238% |
| Codexis, Inc. | -76.24 Million USD | -141.51% |
| Celularity Inc. | -196.29 Million USD | 6.199% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 14.172% |
| Celcuity Inc. | -63.77 Million USD | -188.695% |
| Virax Biolabs Group Limited | -6.73 Million USD | -2634.477% |
| Cibus, Inc. | -267.62 Million USD | 31.2% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -356.596% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -414.163% |
| IN8bio, Inc. | -30 Million USD | -513.613% |
| Kodiak Sciences Inc. | -260.49 Million USD | 29.315% |
| Annexon, Inc. | -134.23 Million USD | -37.166% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -57.152% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -200.724% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -483.715% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 49.731% |
| Eyenovia, Inc. | -27.26 Million USD | -575.42% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 952.795% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -34316.262% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -140.991% |
| Arcellx, Inc. | -70.69 Million USD | -160.471% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -344.311% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -37.597% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -513.001% |
| Moolec Science SA | -51.78 Million USD | -255.534% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -251.582% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -338.669% |
| Royalty Pharma plc | 1.13 Billion USD | 116.225% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -35.431% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -1970.75% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -766.756% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -7.256% |
| Humacyte, Inc. | -110.77 Million USD | -66.216% |
| Structure Therapeutics Inc. | -89.62 Million USD | -105.453% |
| 89bio, Inc. | -142.18 Million USD | -29.495% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -167.006% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -1674.376% |
| Genelux Corporation | -28.29 Million USD | -550.694% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -533.501% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -3.957% |
| Notable Labs, Ltd. | -11.26 Million USD | -1534.65% |
| Liquidia Corporation | -78.5 Million USD | -134.551% |
| Mustang Bio, Inc. | -51.6 Million USD | -256.821% |
| Immunovant, Inc. | -259.33 Million USD | 29.001% |
| Quantum-Si incorporated | -95.96 Million USD | -91.879% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -152.752% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -850.039% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -91.819% |
| Acasti Pharma Inc. | -12.85 Million USD | -1332.56% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -719.878% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1053.558% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -0.951% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -4180.513% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1376.56% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -524.35% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -372.266% |
| PepGen Inc. | -78.62 Million USD | -134.181% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -518.519% |
| United Therapeutics Corporation | 984.8 Million USD | 118.697% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -727.165% |
| Solid Biosciences Inc. | -96.01 Million USD | -91.769% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -3742.811% |
| Immuneering Corporation | -53.47 Million USD | -244.345% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -3519.539% |
| Silo Pharma, Inc. | -3.7 Million USD | -4875.487% |
| Belite Bio, Inc | -31.63 Million USD | -482.091% |
| XOMA Corporation | -40.83 Million USD | -350.949% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -238.687% |
| Bionomics Limited | -15.49 Billion USD | 98.811% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -119.238% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -531.502% |
| uniQure N.V. | -308.47 Million USD | 40.311% |
| Cassava Sciences, Inc. | -97.21 Million USD | -89.398% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2418.244% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -49.175% |
| Forte Biosciences, Inc. | -31.47 Million USD | -484.976% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -2144.985% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -533.435% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -34316.262% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -601.918% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1016.937% |
| Altimmune, Inc. | -88.44 Million USD | -108.178% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -21.469% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -531.502% |
| Compugen Ltd. | -18.75 Million USD | -881.801% |
| Peak Bio, Inc. | -1259.26 USD | -14621741.399% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -299.85% |
| Benitec Biopharma Inc. | -21.75 Million USD | -746.522% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 45.652% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -121.963% |
| Zura Bio Limited | -60.36 Million USD | -205.048% |
| PolyPid Ltd. | -23.86 Million USD | -671.536% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1070.398% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -121.963% |
| Instil Bio, Inc. | -156.08 Million USD | -17.964% |
| argenx SE | -295.05 Million USD | 37.595% |
| Immunome, Inc. | -106.8 Million USD | -72.394% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -333.301% |
| Verona Pharma plc | -54.36 Million USD | -238.662% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -84.28% |
| Shattuck Labs, Inc. | -87.29 Million USD | -110.918% |
| CervoMed Inc. | -2.17 Million USD | -8377.798% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -47.714% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1282.75% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -322.746% |
| Moolec Science SA | -51.78 Million USD | -255.534% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1064726.943% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -36.272% |
| AnaptysBio, Inc. | -163.61 Million USD | -12.534% |
| Design Therapeutics, Inc. | -66.86 Million USD | -175.384% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -126.161% |
| NeurAxis, Inc. | -14.62 Million USD | -1158.843% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -386.054% |
| Lumos Pharma, Inc. | -34.03 Million USD | -441.009% |
| Achilles Therapeutics plc | -69.66 Million USD | -164.303% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -84.28% |
| 180 Life Sciences Corp. | -19.93 Million USD | -823.632% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 6219.636% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -7259769.964% |
| Nutriband Inc. | -5.48 Million USD | -3256.727% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -82.853% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -278.808% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -138.844% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -442.028% |
| MoonLake Immunotherapeutics | -36 Million USD | -411.361% |
| Palisade Bio, Inc. | -12.3 Million USD | -1396.967% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -337.107% |
| Beam Therapeutics Inc. | -132.52 Million USD | -38.935% |
| Neurogene Inc. | -36.31 Million USD | -406.999% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -12.674% |
| AEON Biopharma, Inc. | -52.55 Million USD | -250.344% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -87.603% |
| Sesen Bio, Inc. | -19.88 Million USD | -826.006% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -157.218% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1371.38% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 58.533% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -65.039% |
| Athira Pharma, Inc. | -117.67 Million USD | -56.475% |
| Vaccinex, Inc. | -20.25 Million USD | -809.224% |
| HCW Biologics Inc. | -24.99 Million USD | -636.677% |
| XOMA Corporation | -40.83 Million USD | -350.949% |
| Nektar Therapeutics | -276.05 Million USD | 33.301% |
| Arvinas, Inc. | -367.3 Million USD | 49.87% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -273389.788% |
| Merus N.V. | -154.93 Million USD | -18.838% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -88.988% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -486.672% |
| Rezolute, Inc. | -68.45 Million USD | -168.96% |
| Clene Inc. | -49.5 Million USD | -271.944% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1093.81% |
| BeyondSpring Inc. | -21.02 Million USD | -775.711% |
| Synlogic, Inc. | -57.28 Million USD | -221.44% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1447.156% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1600.785% |
| Peak Bio, Inc. | -1259.26 USD | -14621741.399% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -392.74% |
| Krystal Biotech, Inc. | 10.93 Million USD | 1784.294% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -28.671% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 43.364% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -3886.326% |
| MannKind Corporation | -11.93 Million USD | -1442.361% |
| Ikena Oncology, Inc. | -68.16 Million USD | -170.116% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -776.169% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -98.129% |
| Gossamer Bio, Inc. | -179.81 Million USD | -2.397% |
| CohBar, Inc. | -11.96 Million USD | -1439.251% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -614.003% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -510.703% |
| Legend Biotech Corporation | -518.25 Million USD | 64.472% |
| Mural Oncology plc | -207.44 Million USD | 11.241% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -48.352% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -906.724% |
| Disc Medicine, Inc. | -76.42 Million USD | -140.912% |
| Champions Oncology, Inc. | -7.27 Million USD | -2430.607% |
| REGENXBIO Inc. | -263.49 Million USD | 30.121% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -1634.907% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -287.595% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -384.755% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -83.827% |
| Vaxart, Inc. | -82.46 Million USD | -123.279% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 55266.99% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -390.449% |
| Cellectis S.A. | -101.05 Million USD | -82.198% |
| Longeveron Inc. | -21.41 Million USD | -759.884% |
| Repare Therapeutics Inc. | -93.79 Million USD | -96.306% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 65.646% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -158.718% |
| Revolution Medicines, Inc. | -436.36 Million USD | 57.805% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -2702.115% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -497.349% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -165.569% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -184.445% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -1776.74% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 105.087% |
| Denali Therapeutics Inc. | -145.22 Million USD | -26.788% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -153015.073% |
| Veru Inc. | -93.15 Million USD | -97.661% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -581.22% |
| Cingulate Inc. | -23.53 Million USD | -682.356% |
| Passage Bio, Inc. | -102.06 Million USD | -80.407% |
| Context Therapeutics Inc. | -23.96 Million USD | -668.342% |
| Exicure, Inc. | -16.91 Million USD | -988.607% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 2.536% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -387.573% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -2729.535% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 0.298% |
| Nuvalent, Inc. | -126.21 Million USD | -45.879% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -1650.98% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -111.935% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -502.825% |
| OmniAb, Inc. | -50.61 Million USD | -263.751% |
| Anew Medical, Inc. | 1.34 Million USD | 13778.299% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1047.566% |
| Lipocine Inc. | -16.35 Million USD | -1026.016% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -177.325% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -189.167% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -336.384% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -283.862% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -828.481% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 65.996% |
| Ocugen, Inc. | -63.07 Million USD | -191.904% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -92.336% |
| Q32 Bio Inc. | -112.96 Million USD | -63.001% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -971.004% |
| Alumis Inc. Common Stock | -154.99 Million USD | -18.797% |
| Equillium, Inc. | -13.33 Million USD | -1280.78% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -205.018% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -2205.092% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -876.738% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -211.647% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -60.772% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -901.891% |
| Dominari Holdings Inc. | -22.88 Million USD | -704.681% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2098.685% |
| vTv Therapeutics Inc. | -20.25 Million USD | -809.269% |
| Bio-Techne Corporation | 168.1 Million USD | 209.531% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 47.704% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 242.897% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -51.132% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -385.324% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -63.462% |
| Nkarta, Inc. | -117.5 Million USD | -56.702% |
| BioCardia, Inc. | -11.57 Million USD | -1491.28% |
| Iterum Therapeutics plc | -38.37 Million USD | -379.86% |